3174 results for «384»
3174 results
Aortic valve disease: guidelines and beyond
22 Nov 2021 – From PCR London Valves 2021
Through this PCR London Valves 2021 session, compare the new ESC aortic valve disease guidelines with the US guidelines, focus on controversies and uncertainties of these AVD guidelines, see how to apply the guidelines using the Heart Team decision-making concept, and appreciate in a live case...
Mitral transcatheter edge-to-edge repair
22 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 session dedicated to mitral transcatheter edge-to-edge repair will enable you to understand this specific therapy by the use of anatomical specimens, imaging, and simulations.
Transcatheter tricuspid valve interventions: prevention of complications and their management
22 Nov 2021 – From PCR London Valves 2021
Watch this session from PCR London Valves 2021 if you want to find out more about the complications you may encounter during transcatheter tricuspid valve procedures, learn more about how to schedule and prepare for these interventions to avoid complications, and get more tips and tricks...
TAVI: the future
22 Nov 2021 – From PCR London Valves 2021
This session from PCR London Valves 2021 particularly focuses on the expected expansions of TAVI to patients at a younger age and with a longer life expectancy, including a virtual live case from Clinique Pasteur, Toulouse, France.
Transcatheter mitral valve implantation
22 Nov 2021 – From PCR London Valves 2021
Shot in the simulation lab at the PCR London Valves 2021 Congress, this session enables you to see some of the anatomical specimens and devices currently used for transcatheter mitral valve replacement and witness a Tendyne implantation from start to finish using a simulated heart.
Mitral valve disease: diagnosis and treatment selection
23 Nov 2021 – From PCR London Valves 2021
In the first part of this PCR London Valves 2021 session, review the quantification of mitral regurgitation and learn how to better approach patients. Then, in the second part, study patient selection for specific types of procedures.
Tricuspid valve disease: state-of-the-art
23 Nov 2021 – From PCR London Valves 2021
Imagine that you are faced with a patient with severe tricuspid regurgitation. You may ask yourself many questions, such as: what could be the prognosis of this patient? What is his/her life expectancy? Is he/she eligible for a particular treatment? What should be the appropriate timing...
Anatomy of the aortic valvar complex with considerations for optimal TAVI positioning
23 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 simulation-based learning session, learn the latest in transcatheter aortic valve implantation, gain an understanding of anatomical features, review imaging modalities to plan and perform procedures, and witness hands-on activities, among others.
Transcatheter mitral valve repair and replacement: optimal technique and procedural refinement
23 Nov 2021 – From PCR London Valves 2021
This PCR London Valves 2021 interactive learning session is designed to review the basics but also the more advanced and complex procedural steps of transcatheter mitral edge-to-edge repair, as this procedure requires a rigorous and standardized technique that can take time to learn.
Tricuspid valve disease: guidelines and beyond
23 Nov 2021 – From PCR London Valves 2021
Watch this PCR London Valves 2021 session to hear about the latest European guidelines on the management of tricuspid valve disease, understand the details behind these guidelines and how they compare with those elsewhere in the world, and, most importantly, find out how Heart Teams can translate...
Coronary access following TAVI
23 Nov 2021 – From PCR London Valves 2021
Using the anatomy and imaging section and simulators, our experts dissect the case of a typical TAVI patient, an 81-year-old male, former smoker, with hypertension, dyslipidemia, and gastric ulcer, symptomatic of effort dyspnea, with marked left ventricular hypertrophy and all the parameters of severe aortic stenosis,...
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Surgical left atrial appendage occlusion in VHD without AF: OPINION Trial
03 Sep 2025
Alex Sticchi provides his take on the results of the OPINION trial presented by Yang Wang at the ESC Congress 2025 in Madrid.
Author
Cardiac biomarkers in patients with asymptomatic severe aortic stenosis: primary biomarker analysis from the EARLY TAVR Trial
01 Apr 2025
Elad Asher provides his take on the primary biomarker analysis from the EARLY TAVR Trial presented by Brian R. Lindman at ACC.25 in Chicago.
Author
